We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Check the tariff classification for peptide nisin standardised with sodium chloride
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Check the tariff classification for components in sets for dental repair.
How to apply for accreditation, comply with your accreditation and packaging waste technical information.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
This page includes summaries of the winning bids for the Future RAN (FRANC) competition
Product Recall for NassifMD Deco-Lift Neck Firming Complex Serum presenting a health risk.
How to do a Getein Biotech rapid nose-only test for COVID-19. Rapid tests show the result on a device that comes with the test.
The MHRA emphasises the importance of national reporting of any suspected adverse incidents associated with the product following CE certification withdrawal and cease of manufacturing.
PHE has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).